Protein blockers act to minimize non-specific adsorption by occupying tissue binding sites prior to incubations.

• A. Block non-specific protein adsorption by occupying binding sites.
• B. Eliminate all antigen epitopes.
• C. Increase tissue autofluorescence.
• D. Dissolve paraffin.

Answer: (A)

Blocking in immunohistochemistry is about reducing non-specific binding by occupying potential binding sites on the tissue before antibodies are applied. When a tissue is fixed and prepared, various sites can attract antibodies non-specifically, leading to unwanted background staining. A blocking solution—often containing proteins like normal serum, bovine serum albumin, or non-fat milk—saturates those sites. With the binding sites already occupied, subsequent antibodies are more likely to bind only to their specific antigen targets, yielding clearer, more specific staining and a better signal-to-noise ratio.

This approach doesn’t remove epitopes or destroy antigens, so it won’t eliminate antigen detection. It also isn’t about increasing autofluorescence or dissolving paraffin—those are unrelated steps in preparation. Blocking is specifically to minimize background by occupying binding sites, improving the reliability of the staining.